IRB 101: Informed Consent Columbia University Medical Center IRB September 22, 2005.

Slides:



Advertisements
Similar presentations
Open Library June 4, 2004 Informed Consent Process and Federal Regulations That Must Be Met to Waive Informed Consent Tracey Craddock Regulatory Compliance.
Advertisements

Marian University is sponsored by the Sisters of St. Francis, Oldenburg. Human Subjects Research and the Marian University Institutional Review Board (IRB)
University Research Ethics Committee Workshop on procedure and data protection issues 30th May 2008.
1 The HIPAA Privacy Rule and Research This presentation will probably involve audience discussion, which will create action items. Use PowerPoint to keep.
RESEARCH COMPLIANCE Agenda 1. No Destruction of local research documents after scanning 2. Training for shipping biological samples/specimens 3. Regulatory.
Informed consent requirements
Research Involving Human Subjects All research involving the participation of human subjects must be submitted for review by the IRB (Institutional Review.
The Consent Process: It’s More Than Just a Form A “10 Minute Training” Brought to you by Cyndi Long, MS, RD, CCRC CU Sports Medicine.
Informed Consent Waivers IRB Health Sciences & Behavioral Sciences University of Michigan /26/20091.
© HRP Associates, Inc. Informed Consent, Parental Permission & Assent Jeffrey M. Cohen, Ph.D., CIP President, HRP Associates, Inc.
INFORMED CONSENT: PROCESS, DOCUMENTATION, ALTERATION AND WAIVERS Suzanne Sparrow.
Institutional Review Boards (IRBs), Informed Consent, and Responsibilities Requirement for IRBs -DHHS: 45 CFR Part 46 -FDA: 21 CFR 56 Requirement for and.
Consenting Withdrawn Subjects for Follow-Up Information Anita Camic Team Leader Research Compliance Administration Tara Bateman Research Compliance Coordinator.
Evaluating Risk 1 IRB CELT Presentation Colleen Donaldson – IRB Administrator Julie Wilkens – IRB Coordinator.
Human Subjects & Research Understanding the protection of human subjects, HSRC, and the nature of the process.
Human Subjects Research Protection February 12, 2010 James Riddle, MCSE, CNE, CIP FHCRC Institutional Review Office
Obtaining Informed Consent: 1. Elements Of Informed Consent 2. Essential Information For Prospective Participants 3. Obligation for investigators.
Research Compliance Office Consent Form Workshop Kristin B. Frazier HRPP Education Specialist Research Compliance Office January 24, 2008.
8 Criteria for IRB Approval of Research 45 CFR (a)
IMDMC Reg 101 Course Clinical Research and IDEs
Ethics in Research Stangor Chapter 3.
IRB 101: IRB Review Criteria; Tips for Submission
UTHSC Institutional Review Board (IRB)
Research Methods for the Social Sciences: Ethics Ryan J. Martin, Ph.D. Thomas N. Cummings Research Fellow March 9, 2010.
How to Avoid Problems in the Informed Consent Process Shannon Ontiveros, MS, CIP, CIM Institutional Review Board.
Northeastern University IRB Division of Research Integrity Application process takes 2-8 weeks.
HRPP Training – Session Two Human Research Protection Program Manager
Institutional Review Board (IRB) Human Subject Dr. John N. Austin, Director and Ms. Renee S. Jones, Associate Director Delaware State University Office.
Research Involving Human Subjects All research involving the participation of human subjects must be submitted for review by the IRB (Institutional Review.
1 Donor’s Written Statement of Understanding Beth H. Shaz, MD Chief Medical Officer New York Blood Center Clinical Associate Professor Emory University.
May I have your permission please? The consent process: What, Where, When, Who and Why Valerie Smith OHRP IRB Program Manager
Marian University is sponsored by the Sisters of St. Francis, Oldenburg. Human Subjects Research and the Marian University Institutional Review Board (IRB)
INFORMED CONSENT The Ethical Principle The Regulations The Document The Process What Should It All Mean To Me?
Deception in Human Research Learning Objectives Define Deception and Incomplete Disclosure Understand when Deception or Incomplete Disclosure are allowable.
Welcome New IRB Members! Today we will discuss: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
Case Studies: Puzzles in Human Research Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst, Program for Research Integrity Development and Education.
Legally Effective Informed Consent VA Requirements Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and.
Regulatory requirements: children, assent, and consent waivers and waiver of documentation Bob Craig, 2007.
Donna B. Konradi, DNS, RN, CNE GERO 586 Understanding the Ethics of Research.
Copyright  2000 by Dr. ?????????, Wright State University Dr. ???????? Department of Biomedical, Human Factors, & Industrial Engineering Institutional.
Informed Consent Process Patrick Herbison, MEd, CIP Research Compliance Manager Office of Human Research (OHR)
Avenues of Consent Options available under 45 CFR (d) &
 The purpose of IRB is to ensure the rights of research subjects are protected  In accordance with the ethical standards of the U.S. Department of Health.
Ethics in Research Each research study involves a careful risk/benefit analysis prior to beginning data collection. The question each researcher must ask.
Informed Consent Presented by Marian Serge, RN. Goals Informed consent process and form Title 38 CFR , Common Rule required elements and additional.
Informed Consent It’s a Process …not a form. Outline  Historical Background  Respect for Persons  Consent Process  Elements of Informed Consent 
Informed Consent Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic Compliance, Corporate Compliance.
UCR IRB–SB Reviewer Placemat
TOPAZ Elements The Consent Form Texas Southern University
Arkansas Tech University Institutional Review Board
Upcoming Changes to the Common Rule
Beverley Alberola, CIP Associate Director, Research Protections
Approval Criteria – Informed Consent
Enrolling in Clinical Trials
J. Andrew Bertolatus MD Internal Medicine IRB/HSO 13 Sept 2017
J. Andrew Bertolatus MD Internal Medicine IRB/HSO 12 Apr 2017
J. Andrew Bertolatus MD Internal Medicine IRB/HSO 13 September 2017
UCR IRB–SB Reviewer Placemat
© 2016 The McGraw-Hill Companies, Inc.
Common Rule Changes to Consent and Template
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
This takes approximately 5 minutes or less from start to finish
Informed Consent in the Era of the Revised Common Rule
Elements of a Successful Informed Consent
Jeffrey M. Cohen, Ph.D. Associate Dean,
Informed Consent (SBER)
Consent Form Workshop Kristin B. Frazier HRPP Education Specialist
Revised Common Rule: Informed Consent Changes
Office of Research Integrity and Protections
Ivor Pritchard, Ph.D. April12, 2019
Presentation transcript:

IRB 101: Informed Consent Columbia University Medical Center IRB September 22, 2005

Objectives 1.HHS, FDA Regulations, NY State Law Regarding Informed Consent 2.Waiver of Some or All of the Elements of Informed Consent 3.Waiver of Documentation of Informed Consent 4.Consent Form Tips

Required Elements of Consent 45 CFR & 21 CFR 50.24, 25, 27 1.A statement that the study involves research, an explanation of the purposes of the research and the expected duration of the subject's participation, a description of the procedures to be followed, and identification of any procedures which are experimental; 2.A description of any reasonably foreseeable risks or discomforts to the subject; 3.A description of any benefits to the subject or to others which may reasonably be expected from the research; 4.A disclosure of appropriate alternative procedures or courses of treatment, if any, that might be advantageous to the subject;

Required Elements of Consent (continued) 5.A statement describing the extent, if any, to which confidentiality of records identifying the subject will be maintained; 6.For research involving more than minimal risk, an explanation as to whether any compensation and an explanation as to whether any medical treatments are available if injury occurs and, if so, what they consist of, or where further information may be obtained; 7.An explanation of whom to contact for answers to pertinent questions about the research and research subjects' rights, and whom to contact in the event of a research-related injury to the subject; and 8.A statement that participation is voluntary, refusal to participate will involve no penalty or loss of benefits to which the subject is otherwise entitled, and the subject may discontinue participation at any time without penalty or loss of benefits to which the subject is otherwise entitled.

Additional Elements of Consent, if Appropriate 1.A statement that the particular treatment or procedure may involve risks to the subject (or to the embryo or fetus, if the subject is or may become pregnant) which are currently unforeseeable; 2.Anticipated circumstances under which the subject's participation may be terminated by the investigator without regard to the subject's consent; 3.Any additional costs to the subject that may result from participation in the research; 4.The consequences of a subject's decision to withdraw from the research and procedures for orderly termination of participation by the subject; 5.A statement that significant new findings developed during the course of the research which may relate to the subject's willingness to continue participation will be provided to the subject; 6.The approximate number of subjects involved in the study. 7.If FDA Regulated, the subject must sign and date the consent form.

Waiver of Informed Consent 45 CFR (d) 4 Criteria: 1.The research involves no more than minimal risk to the subjects; 2.The waiver or alteration will not adversely affect the rights and welfare of the subjects; 3.The research could not practicably be carried out without the waiver or alteration; and 4.Whenever appropriate, the subjects will be provided with additional pertinent information after participation.

Waiver of Informed Consent Note: DOES NOT APPLY TO FDA REGULATED RESEARCH Note: DOES NOT APPLY TO FDA REGULATED RESEARCH N.Y. State does now allow for waiver of consent in research involving medical experimentation, unless regulated by the U.S. government

Waiver of Documentation of Informed Consent 45 CFR (c) 1.The only record linking the subject and the research would be the consent document and the principal risk would be potential harm resulting from a breach of confidentiality. Each subject will be asked whether the subject wants documentation linking the subject with the research, and the subject's wishes will govern; 2.The research presents no more than minimal risk of harm to subjects and involves no procedures for which written consent is normally required outside of the research context. Note: DOES NOT APPLY TO FDA REGULATED RESEARCH

Genetic Privacy Law N.Y.State Law, Article 7, Section 79-1 No person shall perform a genetic test on a biological sample taken from an individual without their prior written informed consent

Consent Form Tips 1.Always write in the second person (“You will…”) 2.Use the Consent Form Builder sample texts for the general statements 3.If you will apply for a Certificate of Confidentiality, include the required language in the consent form in the initial submission 4.Consent form language should not exceed 6 th to 8 th grade reading level 5.Ensure consistent information throughout protocol submission and consent form 6.Parental permission- if greater than minimal risk, insert 2 parental signature lines 7.Consider the signature lines before adding them to your consent form 8.If using more than 1 consent form, title them differently when attaching them to your submission 9.Review your consent document for typos and errors before submitting 10.Use the OHRP checklist of consent elements before submitting

CUMC IRB WEB SITE CONSENT FORM GUIDANCE